Literature DB >> 2049173

The use of the in vitro toxin binding inhibition (ToBI) test for the estimation of the potency of tetanus toxoid.

C F Hendriksen1, J W van der Gun, F R Marsman, J G Kreeftenberg.   

Abstract

The in vitro toxin binding inhibition (ToBI) test was used to determine antitoxin responses in mice immunized with tetanus toxoid. The ToBI test showed good correlation with the in vivo toxin neutralization (TN) test in titration of sera of mice immunized with various doses of DPT-Polio, DT-Polio and a tetanus reference preparation. Estimates of potency of tetanus toxoid obtained in mice by ToBI test correlated significantly with those obtained in mice by the lethal challenge test. In addition, potency values of the European reference preparation, succeedingly estimated by ToBI test and lethal challenge test in a single group of guinea-pigs, showed good correlation. From the study it is concluded that the ToBI test is a promising alternative to the toxic challenge procedure in the potency assay of tetanus toxoid vaccines. A substantial refinement and reduction in the use of animals can be achieved. Additional savings can be made by combining diphtheria and tetanus potency testing.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049173     DOI: 10.1016/1045-1056(91)90020-k

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  4 in total

1.  Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam.

Authors:  H A Hong; N T Ke; T N Nhon; N D Thinh; J W van der Gun; J T Hendriks; J G Kreeftenberg
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

2.  Use of immuno assays during the development of a Hemophilus influenzae type b vaccine for technology transfer to emerging vaccine manufacturers.

Authors:  Ahd Hamidi; Hans Kreeftenberg
Journal:  Hum Vaccin Immunother       Date:  2014-11-13       Impact factor: 3.452

3.  A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.

Authors:  Xinran Li; Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  J Control Release       Date:  2015-02-28       Impact factor: 9.776

4.  Serological Monitoring Is Key To Sustain Progress of the Maternal and Neonatal Tetanus Elimination Initiative.

Authors:  Myron M Levine; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2016-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.